ISSN 1662-4009 (online)

Previous issue | Volume 17 | ESPEYB17 | Next issue

Yearbook of Paediatric Endocrinology 2020

ey0017.12-1 | Type 2 Diabetes | ESPEYB17

12.1. Outcomes in patients with hyperglycemia affected by covid-19: Can we do more on glycemic control?

C Sardu , N D’Onofrio , ML, et al. Balestrieri

To read the full abstract: Diabetes Care. 2020. doi: 10.2337/dc20-0723Short summary: In this observational cohort of hospitalised COVID-19 patients in Italy, patients who had hyperglycaemia, with or without diabetes, were at higher risk for severe COVID disease than normoglycaemic patients. Insulin infusion was effective for achieving glycaemic targets and reducing mortality in patients...

ey0017.12-2 | Type 2 Diabetes | ESPEYB17

12.2. Changes in the incidence and prevalence of type 1 and type 2 diabetes among 2 million children and adolescents in hungary between 2001 and 2016 - a nationwide population-based study

L Barkai , Z Kiss , G, et al. Rokszin

To read the full abstract: Arch Med Sci. 2020;16(1):34–41. doi: 10.5114/aoms.2019.88406Short summary: Alarming numbers are reported here on the high prevalence of T2DM in children and adolescents in Hungary. In this nationwide population-based study, the prevalence of T2DM in children aged 0–18 years rose between 2001 and 2006 from 20/100 000 to 36/100 000 and decreased ...

ey0017.12-3 | Type 2 Diabetes | ESPEYB17

12.3. NIPA2 regulates osteoblast function by modulating mitophagy in type 2 diabetes osteoporosis

W Zhao , W Zhang , H Ma , M Yang

To read the full abstract: Sci Rep. 2020;10(1):3078. doi: 10.1038/s41598-020-59743-4Short summary: This study describes a specific mechanism of reduced bone formation secondary to hyperglycaemia. In hyperglycaemic states, advanced glycation end products (AGEs) downregulate the highly selective magnesium transporter expression of NIPA2 in osteoblasts. This results in ma...

ey0017.12-4 | Type 2 Diabetes | ESPEYB17

12.4. Evaluation of the longitudinal change in health behavior profiles across treatment groups in the TODAY clinical trial

JL Kaar , SJ Schmiege , K, et al. Drews

To read the full abstract: Pediatr Diabetes. 2020;21(2):224–32. doi: 10.1111/pedi.12976Short summary: This high-quality, longitudinal lifestyle intervention, with ample funding, had little effect on improving health behaviour profiles of adolescents with T2DM.Comment: The first sweeping recommendation for adolescents with obesity, and certainly for ...

ey0017.12-5 | Type 2 Diabetes | ESPEYB17

12.5. Liraglutide in children and adolescents with type 2 diabetes

WV Tamborlane , M Barrientos-Perez , U, et al. Fainberg

To read the full abstract: N Engl J Med. 2019;381(7):637–46. doi: 10.1056/NEJMoa1903822Short summary: Liraglutide is superior to placebo in improving glycaemic control in children and adolescents with T2DM.Comment: Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, also known as an incretin mimetic. It causes glucose-dependent sti...

ey0017.12-6 | Type 2 Diabetes | ESPEYB17

12.6. Effect of surgical versus medical therapy on diabetic kidney disease over 5 years in severely obese adolescents with type 2 diabetes

P Bjornstad , K Hughan , MM, et al. Kelsey

To read the full abstract: Diabetes Care 2020;43(1):187–95. doi: 10.2337/dc19-0708Short summary: Over 5 years follow-up, bariatric surgery compared with medical treatment resulted in dramatic attenuation of diabetic kidney disease (DKD) in adolescents with T2DM and severe obesity, beyond the impact of improved glycaemic control and weight loss.Comment</em...

ey0017.12-7 | Type 2 Diabetes | ESPEYB17

12.7. Dissecting racial bias in an algorithm used to manage the health of populations

Z Obermeyer , B Powers , C, et al. Vogeli

To read the full abstract: Science 2019;366(6464):447-53. doi: 10.1126/science.aax2342Short summary: Dissecting racial bias in health care systems revealed that a type of software program, which determines who receives access to high-risk health care management, routinely accepts healthier whites ahead of blacks who are less healthy.Comment: The yea...